Torii Pharmaceutical Co (TSE:4551) Days Sales Outstanding : 191.21 (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Torii Pharmaceutical Co Days Sales Outstanding?

Torii Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was 円28,186 Mil. Torii Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was 円13,451 Mil. Hence, Torii Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 191.21.

The historical rank and industry rank for Torii Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

TSE:4551' s Days Sales Outstanding Range Over the Past 10 Years
Min: 139.49 Med: 164.62 Max: 221.93
Current: 166.18

During the past 13 years, Torii Pharmaceutical Co's highest Days Sales Outstanding was 221.93. The lowest was 139.49. And the median was 164.62.

TSE:4551's Days Sales Outstanding is ranked worse than
92.09% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.15 vs TSE:4551: 166.18

Torii Pharmaceutical Co's Days Sales Outstanding increased from Mar. 2023 (174.24) to Mar. 2024 (191.21).

Torii Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Torii Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torii Pharmaceutical Co Days Sales Outstanding Chart

Torii Pharmaceutical Co Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

221.93

193.04

159.12

167.50

171.58

Torii Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															174.24	150.44	168.12	160.22	191.21

Competitive Comparison of Torii Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Torii Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Torii Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torii Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Torii Pharmaceutical Co's Days Sales Outstanding falls into.

Torii Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Torii Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (22865	+	28502)	/	2 )	/	54637	*	365
=	25683.5					/	54637	*	365
=	171.58

Torii Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (28502	+	27870)	/	2 )	/	13451	*	365 / 4
=	28186					/	13451	*	365 / 4
=	191.21

Torii Pharmaceutical Co (TSE:4551) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Torii Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Torii Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Torii Pharmaceutical Co (TSE:4551) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torii Pharmaceutical Co Ltd (TSE:4551) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Torii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho, 3-chome, Chuo-ku, Tokyo, JPN, 103-8439

Website

http://www.torii.co.jp

Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.

Torii Pharmaceutical Co (TSE:4551) Headlines

No Headlines